Syndax Pharmaceuticals (SNDX) Enterprise Value Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) Enterprise Value Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.67% |
| Dec 31, 2025 | 5.83% |
| Sep 30, 2025 | 9.88% |
| Jun 30, 2025 | -8.48% |
| Mar 31, 2025 | 63.62% |
| Dec 31, 2024 | 71.24% |
| Sep 30, 2024 | 58.79% |
| Jun 30, 2024 | 71.77% |
| Mar 31, 2024 | -586.22% |
| Dec 31, 2023 | -19.94% |
| Sep 30, 2023 | -330.95% |
| Jun 30, 2023 | -206.20% |
| Mar 31, 2023 | 84.09% |
| Dec 31, 2022 | -114.25% |
| Sep 30, 2022 | -8.09% |
| Jun 30, 2022 | 48.57% |
| Mar 31, 2022 | -473.87% |
| Dec 31, 2021 | -92.32% |
| Sep 30, 2021 | -25.81% |
| Jun 30, 2021 | -35.52% |